Featured on September 2023 Featured Report
More from September 2023 Featured Report
May 17, 2024
J&J expands immunotherapy portfolio with $850m Proteologix buy
Bolt Bio cuts workforce by 50% to refocus pipeline
Lonza talks recovery, CAPEX, and BIOSECURE as it eyes 2024 growth
Novo buying up ‘more of its supply chain’ in Single Use Systems deal